BRANFORD, Conn., Oct. 24 /PRNewswire-FirstCall/ -- Neurogen Corporation , a drug discovery and development company, announced today that President and CEO William H. Koster will present at the Rodman & Renshaw 7th Annual Healthcare Conference on Monday, November 7, 2005 at 3:50 p.m. E.T.
This presentation is being webcast live from the New York Palace Hotel in New York City and may be accessed through the investor relations section of the Company's web site: http://www.neurogen.com. The webcast will be also be archived in this section, under "Events Calendar & Past Events Replay."
About Neurogen
Neurogen Corporation is a drug discovery and development company focusing on small molecule drugs to improve the lives of patients suffering from disorders with significant unmet medical need, including pain, insomnia, depression, inflammation, and obesity. Neurogen has generated a portfolio of compelling new drug candidates through its Accelerated Intelligent Drug Discovery (AIDD(TM)) system, its expertise in cellular functional assays, and its depth in medicinal chemistry. Neurogen conducts its research and development independently and, when advantageous, collaborates with world- class pharmaceutical companies.
Neurogen CorporationCONTACT: Elaine Grimsell Dodge, Neurogen Corp., +1-203-315-4615,edodge@nrgn.com
Web site: http://www.neurogen.com//
